The NOPAIN for Veterans Act aims to expand access to non-opioid pain management options for veterans within the Department of Veterans Affairs (VA) healthcare system. It mandates the Secretary of Veterans Affairs to include specific non-opioid pain management drugs or biological products in the VA's national formulary and drug standardization list. These products are defined as those approved by the Food and Drug Administration (FDA) for reducing postoperative pain or producing postsurgical/regional analgesia without interacting with opioid receptors. The VA must add these non-opioid treatments within one year of their eligibility for certain federal payment programs. Furthermore, the bill prohibits the use of funds from the Cost of War Toxic Exposures Fund for these amendments and requires the Secretary to implement these provisions within 90 days of the Act's enactment, thereby ensuring timely availability of these alternative pain relief methods for veterans.